Postmenopausal Vaginal Atrophy Treatment Market Scope
Postmenopausal vaginal atrophy is the thinning of the walls of the vagina caused by decreased estrogen levels. This most commonly occurs after menopause. Women with vaginal atrophy have a greater chance of chronic vaginal infections and urinary function problems. The most common symptoms of vaginal atrophy are dryness, irritation, and pain during intercourse. The postmenopausal vaginal atrophy Treatment market is expected to grow in the future due to rising awareness about the treatment among the women and rising R& D activities for new treatments.
The Postmenopausal Vaginal Atrophy Treatment market study is segmented and major geographies with country level break-up.
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Postmenopausal Vaginal Atrophy Treatment market throughout the predicted period.
Actavis Generics (United States), Bionovo (Saudi Arabia), Endoceutics, Inc. (Canada), Upsher-Smith Laboratories, LLC (United States), Novo Nordisk A/S (Denmark), Pfizer Inc. (United States), Teva Pharmaceutical Industries Ltd. (Isreal), Therapeutics MD, Inc. (United States), Shionogi & Company, Limited (Japan), Allergan plc (Ireland), Ligand Pharmaceuticals (United States) and Bayer HealthCare LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Pantarhei Bioscience (Netherland) and VYNE Therapeutics Inc. (United States).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Postmenopausal Vaginal Atrophy Treatment market by Type, Application and Region.
On the basis of geography, the market of Postmenopausal Vaginal Atrophy Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In Mar 2020, Menlo Therapeutics Inc announced the completion of its merger with Foamix Pharmaceuticals Ltd. following the satisfaction of all closing conditions required by the merger.
In Nov 2019, Endoceutics announced the approval of INTRAROSA by Health Canada for the treatment of postmenopausal vulvovaginal atrophy. INTRAROSA is offered as a vaginal ovule containing 6.5 mg of and prasterone.
- High Demand for Effective Treatment for Postmenopausal Vaginal Atrophy
- Rising Prevalence of Postmenopausal Vaginal Atrophy
- Growth in the Healthcare Infrastructure in Developing Regions
- Rising R&D Activities in Postmenopausal Vaginal Atrophy Treatment
- Growing Healthcare Industry Worldwide
- Technological Advancements in the Medical Science
- Stringent Government Rules and Regulations
Key Target AudiencePostmenopausal Vaginal Atrophy Treatment Provider, Potential Investors, Research Firm, Government Bodies, Healthcare Industry and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase